Literature DB >> 7625535

Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.

M Boussinesq1, J P Chippaux, J C Ernould, D Quillevere, J Prod'hon.   

Abstract

Mass treatments with ivermectin have been undertaken each year since 1987 in an area hyperendemic for onchocerciasis in northern Cameroon. The impact of these successive treatments on the incidence of infection in humans was evaluated by comparing the prevalence of skin microfilariae (PMF) and the mean microfilarial skin densities (MFD) observed in 1987 and 1992 in 5-7-year-old children who had never taken the drug but who were members of the treated communities. In 1992, the PMF and the MFD in children in this age group who never received ivermectin were reduced by 55% and 77%, respectively, in comparison with the values observed in 1987, before the first treatment round. These results reflect a pronounced reduction in the intensity of the transmission of Onchocerca volvulus in the treatment zone. The influence of the ivermectin treatment coverage in the human population, as well as the vectorial capacity and the dispersal of the vector blackflies, on the transmission of onchocerciasis is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625535

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Modeling targeted ivermectin treatment for controlling river blindness.

Authors:  Eric M Poolman; Alison P Galvani
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

Review 2.  Anthelmintics. A comparative review of their clinical pharmacology.

Authors:  N de Silva; H Guyatt; D Bundy
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

3.  Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin.

Authors:  Henri Lucien Fouamno Kamga; Dickson Nsagha Shey; Jules Clement Nguedia Assob; Anna Longdoh Njunda; Peter Nde Fon; Peter Kindong Njem
Journal:  Pan Afr Med J       Date:  2011-11-10

4.  Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin.

Authors:  Alexander Yaw Debrah; Sabine Mand; Yeboah Marfo-Debrekyei; John Larbi; Ohene Adjei; Achim Hoerauf
Journal:  Filaria J       Date:  2006-02-05

Review 5.  Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review.

Authors:  Marius Zambou Vouking; Violette Claire Tamo; Carine Nouboudem Tadenfok
Journal:  Pan Afr Med J       Date:  2015-02-27

6.  Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.

Authors:  K Awadzi; Nicholas O Opoku; Simon K Attah; Janis K Lazdins-Helds; Annette C Kuesel
Journal:  Parasit Vectors       Date:  2015-10-09       Impact factor: 3.876

7.  Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.

Authors:  Sasisekhar Bennuru; Sébastien D S Pion; Joseph Kamgno; Samuel Wanji; Thomas B Nutman
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

8.  Factors associated with coverage of praziquantel for schistosomiasis control in the community-direct intervention (CDI) approach in Mali (West Africa).

Authors:  Abdoulaye Dabo; Boubacar Bary; Bourema Kouriba; Oumar Sankaré; Ogobara Doumbo
Journal:  Infect Dis Poverty       Date:  2013-06-10       Impact factor: 4.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.